Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Gains from Sales and Divestitures (2019 - 2021)

Historic Gains from Sales and Divestitures for Phio Pharmaceuticals (PHIO) over the last 3 years, with Q3 2021 value amounting to $2916.0.

  • Phio Pharmaceuticals' Gains from Sales and Divestitures fell 2289.79% to $2916.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $2916.0, marking a year-over-year decrease of 2289.79%. This contributed to the annual value of $4282.0 for FY2020, which is 23769.72% up from last year.
  • Latest data reveals that Phio Pharmaceuticals reported Gains from Sales and Divestitures of $2916.0 as of Q3 2021, which was down 2289.79% from $2570.0 recorded in Q2 2021.
  • In the past 5 years, Phio Pharmaceuticals' Gains from Sales and Divestitures registered a high of $69750.0 during Q3 2019, and its lowest value of $1268.0 during Q4 2019.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $3403.0 (2020), whereas its average is $10440.8.
  • Data for Phio Pharmaceuticals' Gains from Sales and Divestitures shows a peak YoY increase of 23769.72% (in 2020) and a maximum YoY decrease of 9457.78% (in 2020) over the last 5 years.
  • Quarter analysis of 3 years shows Phio Pharmaceuticals' Gains from Sales and Divestitures stood at $1268.0 in 2019, then skyrocketed by 237.7% to $4282.0 in 2020, then tumbled by 31.9% to $2916.0 in 2021.
  • Its Gains from Sales and Divestitures stands at $2916.0 for Q3 2021, versus $2570.0 for Q2 2021 and $2570.0 for Q1 2021.